Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-12

AUTHORS

Patricia LoRusso, Geoffrey I. Shapiro, Herbert Hurwitz, Mary Jo Pilat, Janice Chemidlin, Georgia Kollia, Shariq Syed, Bruce Fischer, Eric Masson

ABSTRACT

PURPOSE: Brivanib alaninate, an orally available prodrug of brivanib, is currently under evaluation for the treatment of several malignancies. This study aimed to (1) investigate effects of a high-fat meal on single-dose pharmacokinetics of brivanib in subjects with advanced/metastatic solid tumors and (2) assess the safety and preliminary efficacy of single and multiple doses of brivanib alaninate in this population. METHODS: A two-part study was conducted consisting of a single-dose phase (Part A) and a multiple-dose phase (Part B). In Part A, subjects received a single dose of brivanib alaninate (800 mg) either in a fasting state or following ingestion of a high-fat meal (approximately 951 kcal [15% protein, 33% carbohydrate, 52% fat]); serial blood samples were collected for pharmacokinetic analysis up to 48 h post-dosing. In Part B, subjects received brivanib alaninate (800 mg) once daily until discontinuation. Throughout both phases, subjects were evaluated for adverse events (AEs) and best clinical response. RESULTS: No clinically significant differences in brivanib exposure were observed between fed and fasting subjects in Part A; C (max) was unchanged and AUC(INF) decreased marginally when administered in a fed versus fasted state. In Part A, the incidence of treatment-emergent AEs was broadly similar in a fed or fasted state. Brivanib alaninate was generally well tolerated throughout the study and showed preliminary evidence of antitumor activity. CONCLUSIONS: Consumption of a high-fat meal had no significant effect on brivanib pharmacokinetics. The study further demonstrates the acceptable safety/tolerability profile and antitumor potential of brivanib in patients with advanced malignancies. More... »

PAGES

1377-1385

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-011-1603-2

DOI

http://dx.doi.org/10.1007/s00280-011-1603-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017984841

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21461891


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Food", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Karmanos Cancer Institute, 4100 John R, 48201, Detroit, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LoRusso", 
        "givenName": "Patricia", 
        "id": "sg:person.012616064757.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012616064757.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana Farber Cancer Institute, 44 Binney Street, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shapiro", 
        "givenName": "Geoffrey I.", 
        "id": "sg:person.0752005421.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752005421.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, DUMC 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hurwitz", 
        "givenName": "Herbert", 
        "id": "sg:person.01242177577.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Karmanos Cancer Institute, 4100 John R, 48201, Detroit, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pilat", 
        "givenName": "Mary Jo", 
        "id": "sg:person.01236150777.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236150777.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chemidlin", 
        "givenName": "Janice", 
        "id": "sg:person.01036173754.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036173754.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kollia", 
        "givenName": "Georgia", 
        "id": "sg:person.01150205302.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150205302.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Syed", 
        "givenName": "Shariq", 
        "id": "sg:person.01334614301.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334614301.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fischer", 
        "givenName": "Bruce", 
        "id": "sg:person.01306467014.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306467014.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masson", 
        "givenName": "Eric", 
        "id": "sg:person.014363567577.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002729921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa061884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008302687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2133.2009.09290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016056620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2133.2009.09290.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016056620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.3875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017142861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70285-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018829845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020862106", 
          "https://doi.org/10.1038/nrc2403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-09-0472", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021242839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra0706596", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021959499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-0509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022697644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024792638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025111240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.27.2757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030212761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030500263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e3283161012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030587655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e3283161012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030587655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.2574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035170611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.9908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042277532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.110.033951", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043803559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2008.656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048505634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/02841860903524396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053376167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0708857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053513212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm051106d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm051106d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.26.15_suppl.4111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079374834"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-12", 
    "datePublishedReg": "2011-12-01", 
    "description": "PURPOSE: Brivanib alaninate, an orally available prodrug of brivanib, is currently under evaluation for the treatment of several malignancies. This study aimed to (1) investigate effects of a high-fat meal on single-dose pharmacokinetics of brivanib in subjects with advanced/metastatic solid tumors and (2) assess the safety and preliminary efficacy of single and multiple doses of brivanib alaninate in this population.\nMETHODS: A two-part study was conducted consisting of a single-dose phase (Part A) and a multiple-dose phase (Part B). In Part A, subjects received a single dose of brivanib alaninate (800 mg) either in a fasting state or following ingestion of a high-fat meal (approximately 951 kcal [15% protein, 33% carbohydrate, 52% fat]); serial blood samples were collected for pharmacokinetic analysis up to 48 h post-dosing. In Part B, subjects received brivanib alaninate (800 mg) once daily until discontinuation. Throughout both phases, subjects were evaluated for adverse events (AEs) and best clinical response.\nRESULTS: No clinically significant differences in brivanib exposure were observed between fed and fasting subjects in Part A; C (max) was unchanged and AUC(INF) decreased marginally when administered in a fed versus fasted state. In Part A, the incidence of treatment-emergent AEs was broadly similar in a fed or fasted state. Brivanib alaninate was generally well tolerated throughout the study and showed preliminary evidence of antitumor activity.\nCONCLUSIONS: Consumption of a high-fat meal had no significant effect on brivanib pharmacokinetics. The study further demonstrates the acceptable safety/tolerability profile and antitumor potential of brivanib in patients with advanced malignancies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-011-1603-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors", 
    "pagination": "1377-1385", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "55b0e5524e8023b82e4fb82b2cc684d034240dfec6b7e9223af363f58dff3c3a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21461891"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-011-1603-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017984841"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-011-1603-2", 
      "https://app.dimensions.ai/details/publication/pub.1017984841"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00280-011-1603-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1603-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1603-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1603-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-011-1603-2'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      21 PREDICATES      65 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-011-1603-2 schema:about N1989ed4e19cd40f5bc59f06cdf1ba1c1
2 N2fd6607c2f7c43e3ba1f3324b3825296
3 N32a6e6fe7ac14ac4b98946369021a64e
4 N3680a1eed274479996aecce235a6d76d
5 N3ea3f91148e04a8d966d64751407a144
6 N63a438ec64a942ca888290a68566553c
7 N693068ba1a6a43d0b793cc2ed6444583
8 N6dfb9b5ead7b457cae6d5e70efebc7db
9 N70c37104e3d24782b998d51b8971379e
10 N79963366f71e49a487ce14ccc79fddbb
11 N8573659512d747de83255ba8eadbcdf8
12 N94c84e0569e441abac6ab4e477bebe66
13 N9f650cb137e3461f8db8a8125aa40d54
14 Nc137c86a780a4f838cbd6791e9d81fbd
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Nad0ee668601c4bb18080bf0c26b947b7
18 schema:citation sg:pub.10.1038/nrc2403
19 https://doi.org/10.1001/jama.2008.656
20 https://doi.org/10.1016/s1470-2045(08)70285-7
21 https://doi.org/10.1021/jm051106d
22 https://doi.org/10.1056/nejmoa060655
23 https://doi.org/10.1056/nejmoa061884
24 https://doi.org/10.1056/nejmoa0708857
25 https://doi.org/10.1056/nejmra0706596
26 https://doi.org/10.1093/annonc/mdp533
27 https://doi.org/10.1093/annonc/mdq599
28 https://doi.org/10.1097/cad.0b013e3283161012
29 https://doi.org/10.1111/j.1365-2133.2009.09290.x
30 https://doi.org/10.1124/dmd.110.033951
31 https://doi.org/10.1158/1078-0432.ccr-06-1249
32 https://doi.org/10.1158/1078-0432.ccr-08-0509
33 https://doi.org/10.1158/1535-7163.mct-09-0472
34 https://doi.org/10.1200/jco.2005.02.2574
35 https://doi.org/10.1200/jco.2008.20.9908
36 https://doi.org/10.1200/jco.2008.26.15_suppl.4111
37 https://doi.org/10.1200/jco.2009.22.3875
38 https://doi.org/10.1200/jco.2009.27.2757
39 https://doi.org/10.3109/02841860903524396
40 schema:datePublished 2011-12
41 schema:datePublishedReg 2011-12-01
42 schema:description PURPOSE: Brivanib alaninate, an orally available prodrug of brivanib, is currently under evaluation for the treatment of several malignancies. This study aimed to (1) investigate effects of a high-fat meal on single-dose pharmacokinetics of brivanib in subjects with advanced/metastatic solid tumors and (2) assess the safety and preliminary efficacy of single and multiple doses of brivanib alaninate in this population. METHODS: A two-part study was conducted consisting of a single-dose phase (Part A) and a multiple-dose phase (Part B). In Part A, subjects received a single dose of brivanib alaninate (800 mg) either in a fasting state or following ingestion of a high-fat meal (approximately 951 kcal [15% protein, 33% carbohydrate, 52% fat]); serial blood samples were collected for pharmacokinetic analysis up to 48 h post-dosing. In Part B, subjects received brivanib alaninate (800 mg) once daily until discontinuation. Throughout both phases, subjects were evaluated for adverse events (AEs) and best clinical response. RESULTS: No clinically significant differences in brivanib exposure were observed between fed and fasting subjects in Part A; C (max) was unchanged and AUC(INF) decreased marginally when administered in a fed versus fasted state. In Part A, the incidence of treatment-emergent AEs was broadly similar in a fed or fasted state. Brivanib alaninate was generally well tolerated throughout the study and showed preliminary evidence of antitumor activity. CONCLUSIONS: Consumption of a high-fat meal had no significant effect on brivanib pharmacokinetics. The study further demonstrates the acceptable safety/tolerability profile and antitumor potential of brivanib in patients with advanced malignancies.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf Nc0bf78edefff4f618c11343152216ed1
47 Ne56dfab401654e88b30350d65be4eac0
48 sg:journal.1088364
49 schema:name Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors
50 schema:pagination 1377-1385
51 schema:productId N55334b87dc564c19a6bf17d6d9bd779a
52 N993b4f1f5c7f494a828f972c95e3603b
53 N9e54fe6cfe0d4cf1b5a75cd3ce99ed77
54 Ne71d3af41d15404c8d6d2054b1fcdf73
55 Nf198eb34bea14fe08ec847587438a737
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017984841
57 https://doi.org/10.1007/s00280-011-1603-2
58 schema:sdDatePublished 2019-04-11T00:16
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Nfcfd26eed9f34ceebd47c4132678c667
61 schema:url http://link.springer.com/10.1007%2Fs00280-011-1603-2
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N1989ed4e19cd40f5bc59f06cdf1ba1c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Food
67 rdf:type schema:DefinedTerm
68 N1e7c0c8c46ff4dccb9160131e85bdac5 rdf:first sg:person.01036173754.96
69 rdf:rest Ncd470205ddb64596a35d721fc8d42595
70 N2a7e40df74bb41b183af18f1ddc28da3 rdf:first sg:person.0752005421.01
71 rdf:rest Na405748c916c407fab305f70c77ec6f7
72 N2fd6607c2f7c43e3ba1f3324b3825296 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Triazines
74 rdf:type schema:DefinedTerm
75 N32a6e6fe7ac14ac4b98946369021a64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Aged
77 rdf:type schema:DefinedTerm
78 N3680a1eed274479996aecce235a6d76d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Neoplasms
80 rdf:type schema:DefinedTerm
81 N3ea3f91148e04a8d966d64751407a144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Male
83 rdf:type schema:DefinedTerm
84 N4d8ba35ebc65407385b38a9d3fa2c5d7 rdf:first sg:person.014363567577.38
85 rdf:rest rdf:nil
86 N55334b87dc564c19a6bf17d6d9bd779a schema:name pubmed_id
87 schema:value 21461891
88 rdf:type schema:PropertyValue
89 N63a438ec64a942ca888290a68566553c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Adult
91 rdf:type schema:DefinedTerm
92 N693068ba1a6a43d0b793cc2ed6444583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Antineoplastic Agents
94 rdf:type schema:DefinedTerm
95 N6dfb9b5ead7b457cae6d5e70efebc7db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Middle Aged
97 rdf:type schema:DefinedTerm
98 N70c37104e3d24782b998d51b8971379e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Neoplasm Metastasis
100 rdf:type schema:DefinedTerm
101 N79963366f71e49a487ce14ccc79fddbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Alanine
103 rdf:type schema:DefinedTerm
104 N8573659512d747de83255ba8eadbcdf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N94c84e0569e441abac6ab4e477bebe66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Cross-Over Studies
109 rdf:type schema:DefinedTerm
110 N993b4f1f5c7f494a828f972c95e3603b schema:name nlm_unique_id
111 schema:value 7806519
112 rdf:type schema:PropertyValue
113 N9c10a3e96921480fae0f05cf99bb621e rdf:first sg:person.01334614301.44
114 rdf:rest Nd562c03c3d6f45ca8e4032c83c3ce035
115 N9e54fe6cfe0d4cf1b5a75cd3ce99ed77 schema:name readcube_id
116 schema:value 55b0e5524e8023b82e4fb82b2cc684d034240dfec6b7e9223af363f58dff3c3a
117 rdf:type schema:PropertyValue
118 N9f650cb137e3461f8db8a8125aa40d54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Female
120 rdf:type schema:DefinedTerm
121 Na405748c916c407fab305f70c77ec6f7 rdf:first sg:person.01242177577.68
122 rdf:rest Nbcecc959d1ed4dc59ad30d5e9e92f635
123 Nad0ee668601c4bb18080bf0c26b947b7 rdf:first sg:person.012616064757.23
124 rdf:rest N2a7e40df74bb41b183af18f1ddc28da3
125 Nbcecc959d1ed4dc59ad30d5e9e92f635 rdf:first sg:person.01236150777.95
126 rdf:rest N1e7c0c8c46ff4dccb9160131e85bdac5
127 Nc0bf78edefff4f618c11343152216ed1 schema:volumeNumber 68
128 rdf:type schema:PublicationVolume
129 Nc137c86a780a4f838cbd6791e9d81fbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged, 80 and over
131 rdf:type schema:DefinedTerm
132 Ncd470205ddb64596a35d721fc8d42595 rdf:first sg:person.01150205302.12
133 rdf:rest N9c10a3e96921480fae0f05cf99bb621e
134 Nd562c03c3d6f45ca8e4032c83c3ce035 rdf:first sg:person.01306467014.27
135 rdf:rest N4d8ba35ebc65407385b38a9d3fa2c5d7
136 Ne56dfab401654e88b30350d65be4eac0 schema:issueNumber 6
137 rdf:type schema:PublicationIssue
138 Ne71d3af41d15404c8d6d2054b1fcdf73 schema:name dimensions_id
139 schema:value pub.1017984841
140 rdf:type schema:PropertyValue
141 Nf198eb34bea14fe08ec847587438a737 schema:name doi
142 schema:value 10.1007/s00280-011-1603-2
143 rdf:type schema:PropertyValue
144 Nfcfd26eed9f34ceebd47c4132678c667 schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
150 schema:name Clinical Sciences
151 rdf:type schema:DefinedTerm
152 sg:journal.1088364 schema:issn 0344-5704
153 1432-0843
154 schema:name Cancer Chemotherapy and Pharmacology
155 rdf:type schema:Periodical
156 sg:person.01036173754.96 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
157 schema:familyName Chemidlin
158 schema:givenName Janice
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036173754.96
160 rdf:type schema:Person
161 sg:person.01150205302.12 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
162 schema:familyName Kollia
163 schema:givenName Georgia
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150205302.12
165 rdf:type schema:Person
166 sg:person.01236150777.95 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
167 schema:familyName Pilat
168 schema:givenName Mary Jo
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236150777.95
170 rdf:type schema:Person
171 sg:person.01242177577.68 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
172 schema:familyName Hurwitz
173 schema:givenName Herbert
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68
175 rdf:type schema:Person
176 sg:person.012616064757.23 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
177 schema:familyName LoRusso
178 schema:givenName Patricia
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012616064757.23
180 rdf:type schema:Person
181 sg:person.01306467014.27 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
182 schema:familyName Fischer
183 schema:givenName Bruce
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306467014.27
185 rdf:type schema:Person
186 sg:person.01334614301.44 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
187 schema:familyName Syed
188 schema:givenName Shariq
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334614301.44
190 rdf:type schema:Person
191 sg:person.014363567577.38 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
192 schema:familyName Masson
193 schema:givenName Eric
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38
195 rdf:type schema:Person
196 sg:person.0752005421.01 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
197 schema:familyName Shapiro
198 schema:givenName Geoffrey I.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752005421.01
200 rdf:type schema:Person
201 sg:pub.10.1038/nrc2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020862106
202 https://doi.org/10.1038/nrc2403
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1001/jama.2008.656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048505634
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/s1470-2045(08)70285-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018829845
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1021/jm051106d schema:sameAs https://app.dimensions.ai/details/publication/pub.1055949982
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1056/nejmoa061884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008302687
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1056/nejmoa0708857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053513212
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejmra0706596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021959499
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdp533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030500263
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/annonc/mdq599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024792638
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/cad.0b013e3283161012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030587655
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1111/j.1365-2133.2009.09290.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016056620
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1124/dmd.110.033951 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043803559
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1158/1078-0432.ccr-06-1249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002729921
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1158/1078-0432.ccr-08-0509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022697644
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1158/1535-7163.mct-09-0472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021242839
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.2005.02.2574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035170611
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2008.20.9908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042277532
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2008.26.15_suppl.4111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079374834
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2009.22.3875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017142861
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2009.27.2757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030212761
243 rdf:type schema:CreativeWork
244 https://doi.org/10.3109/02841860903524396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053376167
245 rdf:type schema:CreativeWork
246 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
247 schema:name Duke University Medical Center, DUMC 3052, 27710, Durham, NC, USA
248 rdf:type schema:Organization
249 https://www.grid.ac/institutes/grid.254444.7 schema:alternateName Wayne State University
250 schema:name Karmanos Cancer Institute, 4100 John R, 48201, Detroit, MI, USA
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.419971.3 schema:alternateName Bristol-Myers Squibb (United States)
253 schema:name Bristol-Myers Squibb, Route 206 & Province Line Road, 08540, Lawrenceville, NJ, USA
254 rdf:type schema:Organization
255 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
256 schema:name Dana Farber Cancer Institute, 44 Binney Street, 02115, Boston, MA, USA
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...